GlucoTrack slumps ~35% after plans for common stock offering
da-kuk
- GlucoTrack (NASDAQ:GCTK) is planning a public offering of its common shares.
- The Israeli medical device maker plans to use the net proceeds mainly for working capital and general corporate purposes, which may include, acquisitions or other business combinations or investments, marketing activities, administrative matters and capital expenditures.
- Aegis Capital is acting as the sole book-running manager for the offering.
- GCTK -36.67% to $1.71 premarket April 13